检索结果 - Jeremy S. Abramson
- Showing 1 - 20 results of 82
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Efficacy and safety of <scp>CD19</scp>‐directed <scp>CAR‐T</scp> cell therapies in patients with relapsed/refractory aggressive B‐cell lymphomas: Observations from the <scp>JULIET<... 由 Jason R. Westin, Marie José Kersten, Gilles Salles, Jeremy S. Abramson, Stephen J. Schuster, Frederick L. Locke, Charalambos Andreadis
出版 2021Revisão -
10
Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high‐risk patients with diffuse large B‐cell lymphoma 由 Jeremy S. Abramson, Matthew D. Hellmann, Jeffrey A. Barnes, Peter S. Hammerman, Christiana E. Toomey, Tak Takvorian, Alona Muzikansky, Ephraim P. Hochberg
出版 2010Artigo -
11
-
12
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma 由 Przemysław Juszczyński, Jing Ouyang, Stefano Monti, Scott J. Rodig, Kunihiko Takeyama, Jeremy S. Abramson, Wen Chen, Jeffery L. Kutok, Gabriel A. Rabinovich, Margaret A. Shipp
出版 2007Artigo -
13
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma 由 Jeffrey A. Barnes, Ann S. LaCasce, Katherine Zukotynski, David Israel, Yang Feng, Donna Neuberg, Christiana E. Toomey, Ephraim P. Hochberg, George P. Canellos, Jeremy S. Abramson
出版 2010Artigo -
14
-
15
Successful anti‐CD19 CAR T‐cell therapy in HIV‐infected patients with refractory high‐grade B‐cell lymphoma 由 Jeremy S. Abramson, Kelly Irwin, Matthew J. Frigault, Jörg Dietrich, Brianne McGree, Justin T. Jordan, Andrew J. Yee, Yi‐Bin Chen, Noopur Raje, Jeffrey A. Barnes, Benjamin Davis
出版 2019Artigo -
16
The immunophenotypic spectrum of primary mediastinal large B‐cell lymphoma reveals prognostic biomarkers associated with outcome 由 Jacob R. Bledsoe, Robert Redd, Robert P. Hasserjian, Jacob D. Soumerai, Ha Nishino, Daniel F. Boyer, Judith A. Ferry, Lawrence Zukerberg, Nancy L. Harris, Jeremy S. Abramson, Aliyah R. Sohani
出版 2016Artigo -
17
Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma 由 Jeremy S. Abramson, Jon Arnason, Ann S. LaCasce, Robert Redd, Jeffrey A. Barnes, Lubomir Sokol, Robin Joyce, David Avigan, Donna Neuberg, Ronald W. Takvorian, Ephraim P. Hochberg, Celeste M. Bello
出版 2019Artigo -
18
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma 由 Kevin C. Miller, P. Connor Johnson, Jeremy S. Abramson, Jacob D. Soumerai, Andrew J. Yee, Andrew R. Branagan, Elizabeth O’Donnell, Anna Saucier, Caron A. Jacobson, Matthew J. Frigault, Noopur Raje
出版 2022Artigo -
19
Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma 由 Gregory M. Coté, Ephraim P. Hochberg, Alona Muzikansky, Fred H. Hochberg, Jan Drappatz, Steven L. McAfee, Tracy T. Batchelor, Ann S. LaCasce, David C. Fisher, Jeremy S. Abramson, Philippe Armand, Yi‐Bin Chen
出版 2011Artigo -
20
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma 由 Jeffrey A. Barnes, Eric D. Jacobsen, Yang Feng, AS Freedman, Ephraim P. Hochberg, Ann S. LaCasce, Philippe Armand, Robin Joyce, Aliyah R. Sohani, Scott J. Rodig, Donna Neuberg, David C. Fisher, Jeremy S. Abramson
出版 2012Artigo
相关主题
Medicine
Internal medicine
Lymphoma
Oncology
Immunology
Chemotherapy
Biology
Rituximab
Gastroenterology
Antibody
Cancer research
Diffuse large B-cell lymphoma
B cell
Cancer
Chronic lymphocytic leukemia
Genetics
Leukemia
Surgery
Clinical trial
Cyclophosphamide
Astrobiology
Pathology
Refractory (planetary science)
Gene
Immune system
Physics
Environmental health
Ibrutinib
Population
Vincristine